Dipath
Latest round
- Series C
Last raised
- Jul 2026
Total raised
- $18M
Investors
- 10
About Dipath
, doing business as Dipath or Deep Informatics, is a medical software development company. The company develops AI-assisted diagnostic tools with multiple modules through self-developed AI algorithms. It became a permanent director of the Beijing Tumor Pathology Precision Diagnosis Research Society in 2017, obtained the registration certificate of hardware and software Class II medical devices and was approved as a high-tech enterprise in Hangzhou in 2019. In 2020, the company became an AstraZeneca partner. The company works with medical institutions and pharmaceutical companies to provide end-to-end digital pathology platforms, including intelligent slide scanners, the DeepPathAI model, and pathology information management systems. Core capabilities include multi-cancer intelligent diagnosis, remote consultation, slide scanning, cytology screening, and biomarker discovery for drug development. The company generates revenue from the provision of digital pathology software, AI-assisted diagnostic solutions, pathology information management systems, medical imaging technologies, and related services for medical institutions and pharmaceutical companies.
Who invested in Dipath
10 investors across 6 rounds
See all investors in Dipath
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Questions about Dipath
Who invested in Dipath?
Dipath has 10 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dipath raised?
Dipath has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Dipath last raise money?
Dipath's most recent round on record is a Series C, in Jul 2026.
What does Dipath do?
, doing business as Dipath or Deep Informatics, is a medical software development company.
Where is Dipath headquartered?
Dipath is headquartered in Hangzhou, China.
Which VCs invest in companies like Dipath?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back software companies at Dipath's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Dipath? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.